Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outbreak of Diarrhea Caused by a Novel Cryptosporidium hominis Subtype During British Military Training in Kenya.
Toriro R, Pallett S, Woolley S, Bennett C, Hale I, Heylings J, Wilkins D, Connelly T, Muia K, Avery P, Stuart A, Morgan L, Davies M, Nevin W, Quantick O, Robinson G, Elwin K, Chalmers R, Burns D, Beeching N, Fletcher T, O'Shea M. Toriro R, et al. Among authors: wilkins d. Open Forum Infect Dis. 2024 Jan 3;11(1):ofae001. doi: 10.1093/ofid/ofae001. eCollection 2024 Jan. Open Forum Infect Dis. 2024. PMID: 38250201 Free PMC article.
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques.
Abdelaal HFM, Berube BJ, Podell BK, Harband MH, Gary HE, Perez-Jaimes M, Ackart DF, Reese VA, Larsen SE, Pecor T, Wilkins DZ, Parish T, Maloney-Norcross SE, Mecham JB, Hickey AJ, Baldwin SL, Coler RN. Abdelaal HFM, et al. Among authors: wilkins dz. NPJ Antimicrob Resist. 2024 Dec 16;2(1):49. doi: 10.1038/s44259-024-00066-z. NPJ Antimicrob Resist. 2024. PMID: 39843983 Free PMC article.
Lower respiratory tract infections following respiratory syncytial virus monoclonal antibody nirsevimab immunization versus placebo: Analysis from a Phase 3 randomized clinical trial (MELODY).
Arbetter D, Gopalakrishnan V, Aksyuk AA, Ahani B, Chang Y, Dagan R, Esser MT, Hammitt LL, Mankad VS, Saez-Llorens X, Shen D, Leach A, Kelly EJ, Villafana T, Wilkins D. Arbetter D, et al. Among authors: wilkins d. Clin Infect Dis. 2024 Dec 4:ciae596. doi: 10.1093/cid/ciae596. Online ahead of print. Clin Infect Dis. 2024. PMID: 39656748
500 results